New England Journal Of Medicine Interviews
NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:04:56
- More information
Informações:
Synopsis
Did you miss AHA 2024? Listen here to brief discussions of the latest research. Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease. N Engl J Med. DOI: 10.1056/NEJMe2414477.